Net Cash Provided by (Used in) Operating Activities in USD of Vistagen Therapeutics, Inc. from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2010 to Q2 2025.
  • Vistagen Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2025 was -$18.8M, a 73.4% decline year-over-year.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$42.1M, a 63.1% decline from 2023.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$25.8M, a 48.1% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$49.7M, a 9.85% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)

Vistagen Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$18.8M -$7.98M -73.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q2 2024 -$10.9M -$2.98M -37.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q2 2023 -$7.89M +$8.08M +50.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q2 2022 -$16M -$9.8M -159% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q2 2021 -$6.17M -$3.37M -120% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q2 2020 -$2.81M +$1.95M +41.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q2 2019 -$4.76M -$1.63M -51.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q2 2018 -$3.14M -$1M -46.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q2 2017 -$2.13M -$463K -27.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q2 2016 -$1.67M -$848K -103% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q2 2015 -$823K +$189K +18.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q2 2014 -$1.01M -$280K -38.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q2 2013 -$732K -$436K -147% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q2 2012 -$296K +$790K +72.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q2 2011 -$1.09M -$761K -234% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q2 2010 -$325K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22

Vistagen Therapeutics, Inc. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$42.1M -$16.3M -63.1% Apr 1, 2024 Mar 31, 2025 10-K 2025-06-17
2023 -$25.8M +$23.9M +48.1% Apr 1, 2023 Mar 31, 2024 10-K 2025-06-17
2022 -$49.7M -$4.46M -9.85% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2021 -$45.3M -$33.2M -275% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 -$12.1M +$3.68M +23.4% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 -$15.8M -$1.23M -8.46% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-29
2018 -$14.5M -$5.47M -60.4% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-29
2017 -$9.06M Apr 1, 2017 Mar 31, 2018 10-K 2019-06-25
2014 -$2.77M -$643K -30.2% Apr 1, 2014 Mar 31, 2015 10-K 2015-06-29
2013 -$2.13M +$1.34M +38.6% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 -$3.46M +$103K +2.88% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-25
2011 -$3.57M -$2.72M -324% Apr 1, 2011 Mar 31, 2012 10-K 2013-07-18
2010 -$841K Apr 1, 2010 Mar 31, 2011 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.